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Bone morphogenetic protein (BMP) signaling pathways play critical roles in skeletal development 
and new bone formation. Our previous study, however, showed a negative impact of BMP 
signaling on bone mass because of the osteoblast-specific loss of a BMP receptor (i.e. BMPR1A) 
showing increased trabecular bone volume and mineral density in mice. Here, we investigated the 
bone quality and biomechanical properties of the higher bone mass associated with BMPR1A 
deficiency using the osteoblast-specific Bmpr1a conditional knockout (cKO) mouse model. 
Collagen biochemical analysis revealed greater levels of the mature cross-link pyridinoline in the 
cKO bones, in parallel with upregulation of collagen modifying enzymes. Raman spectroscopy 
distinguished increases in the mature to immature cross-link ratio and mineral to matrix ratio in 
the trabecular compartments of cKO femora, but not in the cortical compartments. The mineral 
crystallinity was unchanged in the cKO in either the trabecular or cortical compartments. Further, 
we tested the intrinsic material properties by nanoindentation and found significantly higher 
hardness and elastic modulus in the cKO trabecular compartments, but not in the cortical 
compartments. Four point bending tests of cortical compartments showed lower structural 
biomechanical properties (i.e. strength and stiffness) in the cKO bones due to the smaller cortical 
areas. However, there were no significant differences in biomechanical performance at the material 
level, which was consistent with the nanoindentation test results on the cortical compartment. 
These studies emphasize the pivotal role of BMPR1A in the determination of bone quality and 
mechanical integrity under physiological conditions, with different impact on femoral cortical and 
trabecular compartments.
Keywords
BMP receptor type 1A; collagen cross-links; cortical geometry; bone quality; biomechanical 
properties
Introduction
Bone morphogenetic proteins (BMPs) were originally described as secreted substances that 
can induce ectopic bone formation when implanted subcutaneously [1]. Since then, the 
osteogenic function of BMPs has been extensively examined, mainly using in vitro tissue 
cultured systems [2]. Since the FDA approved the use of BMP2 and BMP7 in clinical 
settings for long bone open fractures, nonunion fractures and spinal fusion, the impact of 
BMPs during fracture healing has been extensively studied [3]. However, the impact of BMP 
signaling in bone homeostasis in a physiological setting has been relatively neglected due to 
the lack of appropriate in-vivo model systems.
BMP signals are mediated by type I and type II serine/threonine kinase receptors. Three type 
I receptors for BMPs (BMPR1A or ALK3, BMPR1B or ALK6, and ACVR1 or ALK2) have 
been identified and characterized [4]. BMPR1A is ubiquitously expressed in most types of 
cells, including osteoblasts. We and others have demonstrated the pleiotropic functions of 
BMP signaling mediated by BMPR1A using a conditional mutant allele for Bmpr1a [5]. Our 
recent study found that disruption of Bmpr1a in an osteoblast-specific manner leads to an 
increase of trabecular bone mass in the femora, spine and ribs [6-9], contrary to what was 
expected based on the osteoinductive functions of BMPs [10, 11]. We found a lower bone 
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formation rate in trabecular compartments of the mutant mice [7, 8]. However, we also 
found that disruption of Bmpr1a in osteoblasts severely compromises osteoclastogenesis 
through alterations in the Wnt-RANKL axis, which subsequently results in the increase in 
bone mass. We also reported that an osteoblast-specific knockout of another type I receptor 
for BMPs, Acvr1, leads to nearly identical phenotypes as Bmpr1a cKO mice, with increases 
of bone mass in many, but not all, of the bones [12]. Most recently, it is reported that 
suppression of BMP signaling by administration of a soluble form of a BMPR1A fusion 
protein in wild-type mice also leads to an increase in bone mass [13]. In the cases of gain-of-
function of BMP4 mouse models, bone mass is reduced [14], while loss-of-function of 
BMP2 results in reduced bone mass [10, 11]. Taken together, these results suggest that the 
functions of BMPs on bone homeostasis are more complicated than what was earlier 
believed; i.e. BMP signaling in osteoblasts activates both osteoblast anabolic function and 
catabolic function through enhancing osteoclastogenesis [2]. In the case of the osteoblast-
specific knockout of Bmp1a and Acvr1, the balance moves to further reduction of catabolic 
function, leading to an increase of trabecular bone mass [7, 8, 12]. The subsequently 
important question is whether the higher bone mass found in the cKO mice leads to 
increases in bone quality and mechanical properties.
Bone mineral density (BMD) has been traditionally used clinically to evaluate bone mass as 
a surrogate for bone strength. However, BMD does not always predict fracture risk [15] and 
it is now well accepted that both bone quality and bone mass are important factors in 
determining bone strength [16]. Bone quality affects biomechanical properties differentially 
depending on the amount and structure of bone matrix (i.e. mineral and collagen fiber) [17]. 
Bone matrices consist primarily of inorganic mineral and organic fibrillar collagen. The 
amount and structure of both the mineral and matrix components contribute to 
biomechanical properties of bone, though mineral contributes more to stiffness whereas 
collagen contributes more to flexibility [18]. Bone strength at the material level (aka tissue 
level) may be determined by the degree of mineralization, collagen properties and the way 
these two components are organized [17].
Covalent intermolecular collagen cross-linking, the final process of collagen biosynthesis, is 
important for the stability of collagen fibrils and to organize mineralization [19]. Collagen 
cross-linking can be divided into two categories, namely, enzymatic and non-enzymatic 
cross-linking. In bone, enzymatic cross-links are considered to be beneficial because they 
have a positive effect on the mechanical properties of bone, within a certain range [20]. 
Enzymatic collagen cross-linking is initiated by the conversion of telopeptidyl lysine (Lys) 
or hydroxylysine (Hyl) residues to the respective aldehydes by the action of lysyl oxidase 
(LOX) and, possibly LOX-like proteins (LOXLs) [20]. The aldehydes produced then 
condense with the juxtaposed ε-amino group of Lys or Hyl on a neighboring molecule to 
form divalent cross-links, which can then spontaneously mature into trivalent cross-links 
[21]. The major divalent cross-links in bone collagen are 
dehydrodihydroxylysinonorleucine/its ketoamine (deH-DHLNL) and 
dehydrohydroxylysinonorleucine/its ketoamine (deH-HLNL), and trivalent cross-links, 
Lysyl Pyridinoline (LP) and Hydroxylysyl Pyridinoline (HP) and pyrrole. The pathway of 
cross-linking is mainly determined by the extent of Lys hydroxylation, a post-translational 
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modification catalyzed by lysyl hydroxylases (LHs) encoded by procollagen lysine, 2-
oxoglutarate 5-dioxygenase, Plods.
Understanding the quality and biomechanical properties of the higher bone mass induced by 
loss of BMPR1A is necessary for developing clinical treatments based on BMP signaling. 
Here, we report for the first time that BMP signaling through BMPR1A in osteoblasts plays 
a critical role in maintaining bone quality, including collagen cross-links and mineralization. 
Loss of BMPR1A signaling in osteoblasts affected bone material quality in femoral cortical 
and trabecular compartments differently, which led to alterations in biomechanical 
properties of femoral bones. Our results uncover novel aspects of BMP signaling in 
biomechanics, bone quality, and bone mass.
Materials and Methods
Animals
Transgenic mice expressing the tamoxifen (TM)-inducible Cre fusion protein Cre-ER™ [22] 
under the control of a 3.2 kb mouse pro-collagen a(I) promoter [23] (Col1-CreER™) were 
generated by pronuclear injection and crossed with floxed Bmpr1a mice [24]. These mice 
were maintained in a 129S6 and C57BL6/J mixed background. TM (150 mg/kg) was 
gavaged to males twice a week from 16 to 20 weeks of age and tissues were collected at 
week 22 (n=12 per group). The resulting mice developed similar bone phenotypes as we 
previously reported [8], including an increase in trabecular thickness and tissue mineral 
density in femoral trabecular compartments (Supplementary table 1) and alterations in 
expression of marker genes for osteoblasts and osteoclasts (data not shown). However, 
unlike our previous report that shows a slight decrease of tissue mineral density in femoral 
cortical compartments, no such changes were found in this parameter (Supplementary table 
2), presumably due to the shorter period of TM treatment.
Femora and 6th ribs were isolated; muscles were removed, and bones were wrapped with 
Ca-PBS soaked gauze and stored at −80C until use. Right femora were used for collagen 
analyses, Raman microscopy and nanoindentation. Left femora were scanned for micro 
computed tomography (μCT) followed by 4-point bending tests. Ribs were used for 
nanoindentation to confirm the findings in the femora. Tibiae were immediately flushed to 
remove bone marrow at the time of dissection and used for RNA extraction. Results were 
analyzed by comparing Bmpr1a cKO (Col1-CreER(+):Bmpr1a fx/fx, cKO, hereafter) and 
littermate controls (Col1-CreER(−): Bmpr1a fx/fx, control, hereafter) that also received TM. 
No side effects on bone morphology and body weight were observed using this TM regimen 
[8]. The animal protocol was approved by the Institutional Animal Care and Use 
Committees at National Institute of Environmental Health Sciences and University of 
Michigan.
Amino acid analysis
The right femora (n=6 each group) were removed and soft tissues were cleaned off the bone 
surface. Bone marrow was removed by flushing with cold PBS and then the samples, 
including both cortical and trabecular compartments, were pulverized to a fine powder under 
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liquid N2 using a Spex Freezer Mill (Spex Metuchen, NJ, USA). Pulverized samples were 
washed with cold PBS and then with cold distilled water several times by repeated 
centrifugation (4,000g), and lyophilized. One milligram of dried sample was hydrolyzed 
with 6N HCl and an aliquot of hydrolysate was subjected to amino acid analysis on a Varian 
high performance liquid chromatography system (Prostar 240/310, Varian, Walnut Creek, 
CA, USA) with a strong cation exchange column (AA-911, Transgenomic, San Jose, CA, 
USA) [25]. Based on the hydroxyproline (Hyp) value, the collagen content was calculated 
and expressed as μg/mg of dried sample. The extent of Lys hydroxylation of collagen was 
calculated by the Hyl residues per 300 residues of Hyp and expressed as mol/mol of 
collagen [26].
Collagen cross-link analysis
An aliquot of whole bone sample used for amino acid analysis was demineralized with 0.5 
M EDTA, 0.05 M Tris-HCl, pH 7.4, for 2 weeks, washed with cold distilled water 
exhaustively and lyophilized. Two milligrams of demineralized collagen was then 
suspended, reduced with standardized NaB3H4 [27], and hydrolyzed with 6N HCl as 
described above. An aliquot of hydrolysate was subjected to amino acid analysis to 
determine Hyp and then the hydrolysate with known amounts of Hyp was analyzed for 
cross-linking on a Varian HPLC system (with AA911 column, see above) linked to an on-
line fluorescence flow monitor (FP-1520, Jasco, Tokyo, Japan) and a liquid scintillation flow 
monitor (500TR series, Packard Instrument, Meriden, CT, USA). The cross-link precursor 
aldehydes (i.e., Hylald and Lysald), the major divalent reducible cross-links deH-DHLNL 
and deH-HLNL were analyzed as their reduced forms, i.e. dihydroxynorleucine (DHNL), 
hydroxynorleucine (HNL), DHLNL and HLNL, respectively. Hereafter, the reduced forms 
will be used to indicate these aldehydes and cross-links. The non-reducible cross-links, 
Lysyl Pyridinoline (LP) and Hydroxylysyl Pyridinoline (HP), were also analyzed 
simultaneously as previous reported [21]. All cross-links were quantified as moles per mole 
of collagen (mol/mol of collagen).
Real-time quantitative RT-PCR
RNA was isolated from left tibia using Trizol reagent (Invitrogen) after flushing bone 
marrow. cDNA was synthesized using SuperScript II kit (Invitrogen). Taqman primers and 
probes used in this study were as follows: Plod1, Mm01255760_m1 (74 bp); Plod2, 
Mm00478767_m1 (77 bp); Plod3, Mm00478798_m1 (62 bp); Lox, Mm00495386_m1 (73 
bp); Loxl1, Mm01145738_m1 (109 bp); Loxl2, Mm00804740_m1 (82 bp); Loxl3, 
Mm01184865_m1 (98 bp); Loxl4, Mm00446385_m1 (63 bp). Real-time qRT-PCR was 
performed (ABI 7500 PCR System; Applied Biosystems). Five samples were randomly 
chosen and all measurements were performed in triplicate. Values were normalized to 
GAPDH and analyzed using the 2-ΔΔCt method [28].
Raman microspectroscopy
The Raman system used in this study has been described previously [29]. The right femora 
(n=6 each group) were dehydrated in graded ethanol (70%, 80%, 95%, 100%), defatted in 
Clear-Rite 3 (Richard-Allen Scientific,Kalamazoo, MI, USA), and infiltrated in a liquid 
methylmethacrylate monomer (Koldmount; Mager Scientific). The bones were embedded in 
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poly-methylmethacrylate (Koldmount Cold Mounting Kit; Mager Scientific). Using a low-
speed sectioning saw (Model 650; South Bay Technology, San Clemente, CA, USA) with a 
diamond wafering blade (Mager Scientific), longitudinal sections (>300 μm in thickness) 
were made and subsequently transverse sections were cut at the femoral mid-diaphysis 
(approx. 50% of the total length of femora, Mid) and distal-metaphysis (End). Sections were 
hand polished using wet silicon carbide abrasive discs to make approximately 300 μm thick 
sections [30]. For cortical compartments, areas 10 μm from the surface were chosen in the 
medial quadrant at End and Mid, and both periosteal and endosteal areas were scanned. For 
trabecular compartments, areas 200 – 300 μm from the growth plate were chosen (End), and 
both medial and lateral areas were scanned. At least 3 Raman line spectra were recorded in 
each location. The periosteal and endosteal data within each of the cortical Mid- and End-
diaphysis sections were pooled as no significant differences between location were detected.
At each location, a line-focused 785 nm laser (100 μm in length and 6–8 μm in width) 
(Invictus, Kaiser Optical Systems, Inc., Ann Arbor, MI, USA) was focused on the specimen 
through a NIR-optimized 20X/0.75 objective. Raman scatter was collected through the same 
objective, and delivered to a spectrograph (HoloSpec, Kaiser Optical Systems, Inc.). The 
Raman scatter was collected on a back-illuminated deep depletion CCD (Newton, Andor 
Technology, South Windsor, CT, USA). Spectral processing was performed with locally 
written scripts on Matlab (Math Works, Natick, MA, USA) for spectrograph image 
curvature, dark-current subtraction, white-light correction [31] and background tissue 
fluorescence [32]. The data was exported to GRAMS/AI (Thermo Fisher Scientific, 
Waltham, MA, USA) and spectra were normalized to the height of phosphate ν1 band 
(959cm−1). The number of bands to fit the phosphate ν1 envelope (approx. 900 – 990 cm−1) 
and amide I envelope (approx. 1600-1700 cm−1) was determined by second derivative 
analysis. The phosphate envelope was fitted to three bands at 918, 946 and 959 cm−1). The 
amide I envelope was fitted to four bands at 1605, 1635, 1664 and 1685 cm−1. Band areas 
were determined for select Raman peaks from bone mineral (phosphate, 959 cm−1) and 
collagen matrix (amide I, 1664 and 1685 cm−1) components. For Raman metrics- the 
collagen cross-link (maturity) ratio, (1664 / 1685) indicating cross-link maturation [33], the 
mineral/matrix ratio (959 / [853+876)]) describing the amount of mineralization, and 
crystallinity (inverse of 959 cm−1 bandwidth at half the peak intensity) representing mineral 
crystal size and perfection were calculated [34].
Nanoindentation
After Raman analysis, the femoral sections (n=6 each group) were used to measure the 
material-level mechanical properties by a Nano Indenter II (Nano Instruments, Inc., Oak 
Ridge, TN, USA). Specimens were examined visually under an optical microscope, and at 
least five indentations each in the mid-diaphysis (Mid) and distal-metaphysis (End) were 
made. For cortical compartments, areas 10 μm from surface in the medial quadrant were 
chosen (End and Mid) and for trabecular compartments, areas 200 – 300 μm from a growth 
plate were chosen (End). The indents were made by a diamond Berkovich tip with 30 μm 
spacing between indents, following a constant displacement rate of 20 nm/s to reach the final 
displacement of 500 nm. A typical indentation experiment resulted in a loading and 
unloading force-displacement curve. The elastic moduli E were computed according to 
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Oliver and Pharr’s method [35]. 1 / Er =(1-ν2 ) / E+(1-νi2) / Ei, where ν is Poisson’s ratio of 
the indented specimen, which was set to be 0.3 assuming the bone to be an isotropic elastic 
material; νi is Poisson’s ratio of the indenter tip (equal to 0.07), and Ei is the elastic modulus 
of the indenter material (equal to 1440 GPa). Reduced elastic modulus Er was calculated 
from the slope of a line tangent to the unloading segment of the load-displacement curve at 
peak indentation load. The hardness values H were determined by the following formula: H 
= Pmax / A, where Pmax is the peak indentation load and A is the projected contact area at 
that load. H were computed using the Nano Indenter II® software.
For rib samples (n=3 each group), a nanoindentation system (950 TI TriboIndenter, 
Hysitron, Minneapolis, MN) with a 0.5μm spatial resolution was used. Cortical and 
trabecular regions of interest were located under the microscope. A diamond tip with 
Berkovich geometry was used to perform the indents, which consisted of a 10 μN preload, 
and then a 300 μN/s load rate up to 3,000 μN, which was held for 10 seconds and then 
unloaded at −300 μN/s for 10 seconds. Five indents per compartment per sample were made 
with 15 μm spacing between indents. Load-displacement curves were analyzed to compute 
the indentation modulus (E) using the Oliver-Pharr method [35]. The five modulus and 
hardness values were averaged for each sample.
Micro Computed Tomography (μCT) Evaluation – Geometric Properties
Left femora (n=12 for both controls and cKO) were scanned at the proximal metaphysis and 
the mid-diaphysis using a μCT system (μCT100 Scanco Medical, Bassersdorf, Switzerland). 
Bones were embedded in agarose to prevent dehydration [36]. Scan settings were voxel size 
10 μm, medium resolution, energy 70 kV, intensity 114 μA, 0.5 mm AL filter, and 
integration time 500 ms. Scans were reoriented using Scanco IPL to match the alignment of 
each bone in silico with its eventual alignment during mechanical testing, as described [37]. 
Analysis was performed using the manufacturer’s evaluation software. A 1 mm × 1mm 
region of the trabecular compartment (50 μm thick) was analyzed beginning 0.2 mm below 
the growth plate using a fixed global threshold of 25.5% (255 on a grayscale of 0-1000, 554 
mg HA/cm3). Cross-sectional geometry was measured in a 1.5 mm region of the mid-
diaphysis in the center of the 3 mm zone between the inner loading point, and was analyzed 
using a fixed global threshold of 28% (280 on a grayscale of 0-1000, 628 mg HA/cm3).
Cortical geometry at the mid-diaphysis was analyzed from thresholded slice images using a 
custom Matlab script. Measured properties included cortical area, cortical thickness, 
anterior–posterior (AP) width, medial–lateral (ML) width, bending moment of inertia about 
the AP and ML axes (IAP, IML), the distance between the centroid and the anterior surface 
was measured for use in calculating material level mechanical properties; see Mechanical 
Testing, below.
Mechanical Testing - Four point bending
Whole bone (structural level) mechanical testing by four point bending was performed on 
the left femora (n=12 each) using an Admet eXpert 450 Universal Testing Machine 
(Norwood, MA, USA) and its manufacturer-provided software for data collection. Whole 
femora were brought to room temperature prior to testing, hydrated with calcium buffered 
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saline throughout testing, and aligned in the tester with the anterior surface in tension 
(bending about the medial-lateral axis) and the greater trochanter outside the proximal 
loading roller (9 mm support span, 3 mm loading span). Bones were loaded to failure at a 
crosshead displacement rate of 0.025 mm/s. Load and deflection data were recorded for each 
test and analyzed with the aid of custom Matlab scripts as previously described [30]. During 
testing, the bone was visually monitored and the point of fracture initiation was noted and 
measured relative to the proximal end of the bone. Classic beam theory equations were used 
to calculate estimated stress-strain curves from load-deflection curves using each bone’s 
bending moment of inertia about the testing axis (IML) and the distance to tensile surface (d 
from the centroid to the anterior surface) as measured by μCT at the fracture site. Yield was 
defined using the 0.2% strain offset method [38]. Measures of material-level strength (yield 
stress, ultimate stress, and failure stress) and structure-level strength (yield force, ultimate 
force and failure force) are reported, as well as elastic modulus (the slope of the linear 
portion of the stress-strain curve) and stiffness (the slope of the linear portion of the load- 
displacement curve) [30].
Statistical analysis
All results are expressed as mean ± SD. Student’s t-tests or Mann-Whitney tests when 
normality failed were used to compare data between control and cKO mice; p < 0.05 
indicates significance.
Results
Osteoblast-specific disruption of Bmpr1a leads to a greater level of mature collagen cross-
links in femoral bone
To explore the effect of BMPR1A on collagen content and structure, we first measured 
collagen content (hydroxyproline/dry weight, μm/mg) of whole femora in control and cKO 
mice (Fig. 1A). There were no significant differences between control (159.6 ± 4.1 μg/mg) 
and cKO mice (154.9 ± 4.1 μg/mg). Also, there were no significant differences between 
control and cKO mice regarding Lys hydroxylation (Fig. 1B). These results suggested that 
BMP signaling through BMPR1A in osteoblasts does not play a critical role in determining 
the amount of collagen or its Lys hydroxylation.
The concentrations of cross-link precursor aldehydes (DHNL and HNL), reducible divalent 
cross-links (DHLNL and HLNL) and two nonreducible cross-links (LP and HP) are depicted 
in Fig. 1 C-H. There were no significant changes in aldehydes and reducible cross-links 
(Fig. 1C, D, E, F) between control and cKO mice. Regarding nonreducible cross-links, 
however, HP content was significantly larger by 39% in the cKO mice (Fig. 1G, p < 0.05), 
whereas LP did not change between the two groups (Fig. 1 H).
The amount and type of collagen cross-links are determined by two groups of enzymes, 
LOXs and LHs, respectively [20]. To explore the potential effect of BMPR1A signaling on 
the gene expression of these modifying enzymes, we examined expression of Plod1, 2, and 3 
(encoding LH1, 2, 3) and Lox, Loxl1, 2, 3 and 4 in the tibia. QRT-PCR results showed Plod3 
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and Loxl4 were significantly up-regulated in the cKO bones compared to controls (Fig. 2, *p 
< 0.05, **p < 0.01).
Loss of BMPR1A signaling differentially affects the ratio of mature to immature collagen 
cross-linking in cortical and trabecular compartments of femora.
Since μCT results showed a different impact on cortical and trabecular compartments with 
loss of BMPR1A (Supplementary Table 1 and Supplementary Table 2), we measured cross-
linking patterns in cortical and trabecular compartments separately. By employing Raman 
spectroscopy, the relative % area of the individual underlying bands of Amide I (1664 and 
1685 cm−1) were plotted. In the cortical compartments, the cross-linking ratio did not show 
significant differences between controls and cKO mice (Fig. 3A). In contrast, in the 
trabecular compartments, the ratio in the cKO mice was significantly increased, by 37%, in 
the End region (distal-metaphysis of the femora) (Fig. 3B).
BMPR1A regulates a mineral to matrix ratio in the trabecular compartments of femora
Since the collagen network serves as a template for mineralization, differences in status of 
collagen cross-links found in the Bmpr1a cKO bones may affect the mineralization process. 
Using Raman spectroscopy, we also examined the relative amounts of mineral and matrix 
(mineral/matrix ratio, MMR) in femoral cortical and trabecular compartments. There were 
no significant differences between controls and cKO mice in the femoral cortical 
compartments (Fig. 3C). However, in trabecular compartments, loss of BMPR1A resulted in 
significantly larger MMR by 49% (End) in the cKO mice (Fig. 3D). To assess uniformity of 
the diameter, orientation and distribution of apatite crystals, we examined the crystallinity 
[34]; there were no significant differences between controls and cKO mice in either the 
cortical or trabecular compartments (Fig. 3E, 3F).
Disruption of Bmpr1a leads to greater intrinsic tissue mechanical properties in the 
trabecular compartment
To determine whether the alteration in bone composition by loss of BMPR1A signaling 
influenced femoral biomechanical properties, nanoindentation tests were performed on 
femoral cortical and trabecular compartments. In the cortical compartment, there were no 
significant differences in hardness and elastic modulus between cKO and controls (Fig. 4A, 
C). However, in the trabecular compartment, the cKO bones showed a significant increase in 
hardness versus the controls (Fig. 4B). Moreover, elastic modulus in the bones from cKO 
mice increased significantly compared to bones from control mice (Fig. 4D). Both 
compartments in the ribs from cKO mice showed significant increases in elastic modulus 
compared to bones from control mice (Fig. 4G, H).
Disruption of Bmpr1a results in lower femoral bone strength at the structural level due to 
the decrease in cortical area
To understand the effect of loss of BMPR1A on whole bone strength, we performed four 
point bending tests at the mid-diaphysis of femoral cortical compartments. Structural-level 
analyses revealed significantly lower yield force, ultimate force, failure force and stiffness in 
the mutant bones (Fig. 5A, D). These results demonstrated the cKO bones offered less 
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resistance to external loading. However, no changes were found in deformation and work, 
including post-yield properties (Fig. 5B, C).
Next, material-level properties were estimated by normalizing structural-level properties by 
the cross-sectional geometric properties. Cortical area and thickness in the cKO bones were 
significantly lower than controls by 9% (p<0.01) and 7% (p<0.01), respectively (Table 1). 
The medial-lateral width was also decreased in the cKO mice (p<0.01) (Table 1). However, 
upon normalization to femoral cross-sectional geometry, the material-level biomechanical 
properties showed no changes in yield stress, ultimate stress, failure stress or modulus 
between controls and cKO bones (Fig. 5E, H). These results are in agreement with the 
nanoindentation results that showed no change in cortical material-level biomechanical 
properties in the femur (Fig. 4A, C). There were also no significant differences in yield, 
ultimate, failure and post-yield strains, and toughness (Fig. 5F, G).
Discussion
Despite accumulating evidence for the role of BMPs in promoting fracture healing and 
increasing bone mass, the impact of BMP signaling on bone quality and biomechanical 
properties under physiological conditions has not been fully elucidated, due to the lack of 
appropriate genetic animal models. In this study, we deleted Bmpr1a in an osteoblast-
specific manner in mice when they reached 16 weeks of age, and found that the loss of 
BMPR1A signaling in osteoblasts changes femoral geometry (Table 1), composition (Fig. 1, 
3) and biomechanical properties (Fig. 4, 5). Moreover, we found that the cortical and 
trabecular compartments are differentially affected in these properties in the cKO mutants. 
In cortical compartments, the cross-sectional area in the cKO femora is smaller (Table 1), 
which likely contributes to the decreased structural-level strength (Fig. 5). In the trabecular 
compartment, the cKO exhibited a greater mature to immature cross-link ratio and mineral 
matrix ratio (MMR) (Fig. 3), which were associated with greater biomechanical properties 
(Fig. 4). Taken together, these results indicate that BMPR1A is an important factor under 
physiological conditions, for maintaining proper geometry within cortical compartments, 
and bone tissue quality, including collagen cross-linking and mineral deposition within 
trabecular compartments.
Loss of BMPR1A in mice leads to greater material-level modulus and hardness in femoral 
trabecular bone in association with the increased mature cross-links and MMR
Collagen cross-linking plays an important role in bone strength, and is thought to be a 
determinant of bone quality at the material level [39]. Most likely, increased levels of mature 
collagen cross-linking are beneficial for bone strength. In our study, we found increased 
levels of mature cross-links HP in the whole bone (Fig. 1) and an increased mature to 
immature cross-link ratio in the mutant trabecular compartment, accompanied by 
significantly increased mineral to matrix ratio (Fig. 3). These alterations in trabecular 
composition coincide with higher modulus and hardness (Fig. 4). Based on our previous 
study, where we found greater bone mass in trabecular compartments in cKO femora and no 
changes in cortical compartments assessed by microCT [8], we believe the change in HPLC 
data was mainly influenced by trabecular bone, as Raman analyses detected trabecular bone 
Zhang et al. Page 10
Bone. Author manuscript; available in PMC 2017 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
changes in the current study (Fig. 3). Since mouse femora contain more cortical bone than 
trabecular bone, it is possible that there may be some alterations in cortical bone at levels of 
scale that were not probed in this study, or at resolutions smaller than what is detectable with 
the techniques used. However, given the hierarchical approach employed and combination of 
chemical, spectroscopic, imaging mechanical and molecular assays utilized, the collective 
data supports the conclusion of trabecular, but not cortical changes.
Consistent with our results, alfacalcidol treatments improve the strength of fragile bones in 
rats, which is associated with increases of mature cross-links [40]. Moreover, a reduction of 
LP and HP cross-links by inhibiting LOX is also associated with reduced strength in the 
femora of rats [41]. However, association of an increased fracture risk is also reported with 
increased maturity of collagen cross-links in cortical and trabecular compartments of iliac 
biopsies [16]. Such discrepancies may be explained by other changes in bone composition, 
such as increases of crystallinity [16] or increased microheterogeneities in bone matrix 
composition [42]. Further investigation is necessary to better understand how modifications 
of cross-linking in the extracellular matrix contribute to biomechanical properties of bone.
The Raman spectroscopic parameters should be interpreted with care. There are two sources 
of ambiguity in the measurements: the interpretation of components of amide I and the 
interpretation of mineral to matrix ratio. Since its introduction to bone Fourier transform 
infrared spectroscopy (FTIR) [33], the intensity ratio of the ~1660 cm−1 to ~1690 cm−1 
components of amide I (largely C=O stretches of the collagen amide backbone) has been 
used as measure of mature/immature cross-link content. The ratio was soon used in Raman 
spectroscopy [29], where signal/noise ratios are lower than in FTIR. Although it was 
recognized by Paschalis et al. to be only an indirect measure of cross-link content, the ratio 
has since been used in both FTIR and Raman spectroscopies to interpret data from bone in 
which, for example, pathological cross-links might be formed by incubation with ribose [43] 
or by administration of ionizing radiation [44]. The ratio as a measurement of cross-link 
content has come into question because administration of the lysyl oxidase inhibitor beta-
aminopropionitrile (BAPN) was found by one group to cause no change in the enzymatic 
cross-link ratio [45] and by another to cause a change [46]. However, if treatment history 
and tissue age are carefully controlled for, Raman spectroscopy is able to detect localized 
matrix differences attributable to crosslinking changes [37].
The Raman microprobe used in this work employs line-focused laser light with the entrance 
slit of the spectrograph functioning as a spatial filter. This semi-confocal configuration 
results in partial depolarization of the exciting laser light and the Raman scatter due to the 
turbidity of the bone tissue [47]. The tissue orientation effects are partially, but not 
completely eliminated. On the assumption that the relative orientation of phosphate 
crystallites and collagen fibrils remain constant and independent of changes in cross-link 
content and amount of mineral, our estimates of mineral/matrix ratio may be a lower limit. 
However, on the assumption that increasing the cross-link/maturity ratio does not change the 
relative orientations of collagen carbonyls, the observed collagen cross-link/maturity ratio 
will be independent of polarization properties. In this study we used a 20×/0.75 objective. 
Our study of polarization effects in bone spectra obtained with a Raman microprobe using 
the spectrograph entrance slit as the spatial filter found that the slit functions to partially 
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depolarize the light [47]. The reason is that there is no spatial filtering along the slit length. 
The order parameter P2 is reduced from 0.72 to 0.20 when changing from a 40×/0.9 
objective to a 20×/0.75. While polarization effects are not completely eliminated, they are 
greatly attenuated compared to what is obtained with a pinhole spatial filter.
It is not clear if higher levels of HP cross-links are associated with higher MMRs in bones 
from cKO mice. Mineral characteristics contribute to bone mechanical properties [48], and 
the greater stiffness and hardness in the mutant trabecular compartments can potentially be 
explained by the higher MMR. We dehydrated bones for plastic embedding in order to 
perform Raman and nano-indentation. This processing may have an impact on the results, 
especially the mechanical characterization. Dehydration increases elastic modulus [49], thus 
the reported values may be upper limits. However, sample processing would not affect the 
comparative trends [50]. It is possible that the dehydration/embedding process could 
influence control and cKO samples differentially due to the differences in quantity and 
quality of bone composition. However, this scenario is not probable, since much greater 
changes in composition would be required for similar processing methods to manifest 
themselves differently.
The higher levels of mature cross-links in the bones from Bmpr1a cKO mice may be 
attributed to slower bone turnover
In the bones from Bmpr1a cKO mice, the expression of the collagen cross-link associated 
enzyme genes, including Plod3 and Loxl4, was upregulated in the tibia (Fig. 2). LP is a 
trivalent cross-link composed of two telopeptidyl Hylalds, and one helical Hyl, thus, each of 
the three Lys residues involved are hydroxylated. It is possible that upregulation of Plods 
and Loxs in the cKO mice may lead to increases in immature crosslinks, yielding a larger 
number of immature crosslinks. As immature crosslinks convert to mature ones, the number 
of immature crosslinks decreases and the number of mature crosslinks increases over time, 
resulting in a larger number of mature crosslinks in the cKO bones. The increased formation 
of pyridinoline cross-links found in fibrotic disorders patients in association with higher LH 
levels [51] is consistent with our finding. However, although significant, alterations in Plod3 
and Loxl4 gene expression are small and it is not clear that crosslink changes found in tibiae 
can be extrapolated to the femora, where we analyzed collagen crosslinking, since 
compositional changes in bone are site-specific.
A more plausible explanation for the increase of HP in cKO bones is that bone remodeling 
in the cKO mice is slower resulting in an increase in mature cross-links. Collagen cross-link 
formation is tightly regulated by bone turnover rate [52]. As we reported previously, the 
Bmpr1a cKO mice show a slower bone turnover rate in femoral trabecular bones compared 
to bones from control mice due to the reduction in osteoclastogenesis [7, 8]. We observed a 
reduced bone formation rate in the cKO trabecular compartments [7, 8], thus we interpreted 
that trabecular bone mass is increased due to higher reduction in bone resorption than 
increase in bone formation. The reduced level of bone turnover in the mutant bones allows 
the collagen fibrils to mature in the tissue, i.e., once the telopeptideyl lysine and hydroxy-
lysine residues are converted to aldehyde by the action of lysyl oxidase, the subsequent 
divalent and trivalent cross-link reactions are non-enzymatic and spontaneous [53]. This 
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notion is supported by a similar cross-link phenotype seen in toothless (tl/tl) osteopetrotic 
rats and WBN/ Kob diabetic rats in which bone remodeling is diminished [54]. The 
relatively small changes in collagen cross-links that we observed in bones from cKO mice 
could be due to the fact that the analysis was done on the whole bone. Since the changes in 
the Raman spectroscopic parameters are different between trabecular and cortical 
compartments, cross-link analysis after separation of these compartments may provide more 
insight into the role of BMPR1A in collagen phenotypes.
Loss of BMPR1A leads to the reduction in cortical bone strength at the structural level
The strong relationship between cortical area and maximum load suggests that properties of 
the cortical compartment are important for whole bone strength [18, 38]. Loss of BMPR1A 
decreased cortical area and thickness (Table 1). Larger external bone diameters provide 
greater strength in bending than smaller external bone diameters, when other structural and 
compositional parameters are equal (e.g., amount of bone mineral), because resistance to 
load is primarily a function of cross-sectional geometry of long bones [18, 38]. Reduced 
cortical thickness is associated with wrist fractures in women [55]. Therefore, the lower 
whole bone strength, including reductions in yield force, ultimate force, failure force, found 
in the Bmpr1a cKO femora (Fig. 5) may be explained by the reduced cortical cross-sectional 
area. In contrast, we did not find significant differences in deformation, work, strain, and 
toughness including post-yield properties, in cKO bones compared to controls (Fig. 5). Since 
modifications in collagen influence post-yield properties, these results are consistent with 
the lack of significant changes in collagen in cortical bones detected by Raman spectrometry 
(Fig. 3).
We used mid-diaphyseal μCT images to estimate material properties. The CT site was 
located at approximately the mid-point (50%) and its 1.5mm thickness included ~10% of the 
bone length, thus it covered the span that was 45-55% of bone length. On average, bones 
fractured at the 60% point of the length, closer to the distal end. Both the CT and fracture 
sites were within the 4-pt testing 3mm inner span.
Loss of BMPR1A signaling affects femoral cortical and trabecular compartments 
differently
Femoral trabecular and cortical compartments are affected differently by loss of BMPR1A 
signaling. In femoral trabecular compartments, Bmpr1a deficiency increased BMD, MMR, 
mature collagen cross-links, and material level biomechanical properties. In cortical 
compartments, Bmpr1a deficiency negatively affected cross-sectional geometries and thus 
bone strength at the structural level, but material level properties remained unchanged. 
Interestingly, both cortical and trabecular compartments from cKO ribs showed greater 
moduli than in control ribs. These different outcomes may be due to differences in 
anatomical location, origin (lateral mesoderm vs. paraxial mesoderm), or mechanical 
environment.
Several reports have documented different responses of cortical and trabecular 
compartments to genetic manipulation, disease and treatments [56, 57]. One possible 
explanation is a difference in bone turnover rate in these two bone types. Generally, the 
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turnover rate in trabecular compartments is higher than that in cortical compartments [58, 
59]. In our study, we induced Cre activity at 16 weeks by injection of tamoxifen for 5 weeks 
and harvested bones at 22 weeks, but it may not have been long enough for cortical 
compartments to make overt changes. Until 16 weeks, when Cre activity is induced by 
tamoxifen injection, normal bone matrix is formed in both cortical and trabecular 
compartments. After Cre induction, the Bmpr1a deficient osteoblasts change their 
characteristic to lower bone formation rate [8], reduce supporting function for 
osteoclastogenesis [8] and increase some of the collagen modifying enzymes (Fig. 2). Thus, 
bones become a hybrid of normal and newly deposited matrices that have alterations in 
collagen cross-linking and mineral matrix ratio. Therefore, bones showing a higher turnover 
(trabecular compartments) should have higher ratio of matrix deposited after induction of 
Cre recombinase in osteoblasts, leading to the significant alterations in bone quality. An 
interesting future study will be to treat the mice with tamoxifen for longer periods to 
investigate alterations in bone quality and biomechanical properties in femoral cortical 
compartments. However, tamoxifen also influences bone mass. The impact of tamoxifen on 
tissue-level mechanical properties is poorly understood, and thus we need to be mindful of a 
possible impact of long-term treatment of tamoxifen. Nonetheless, control mice also 
received tamoxifen injections, so if there were any influence of tamoxifen on mechanical 
properties, this is accounted for in the phenotypic comparison of cKO to control mice.
There are interesting contrasts between the results of this study and the phenotype of Bmp2 
cKO mice [10, 11]. Removal of Bmp2 in mesenchymal precursors at embryonic day 10.5 
results in smaller cortical compartments and increased fracture risk in adult mice [11]. 
Osteoblast-specific disruption of Bmp2 using type 1 collagen-Cre results in reduced 
trabecular bone volume and mechanical properties at the structural level, but similar cortical 
thickness compared with controls [10]. There are several possibilities to explain such 
differences. Functions of ligands and receptors are not necessarily identical, i.e. a germline 
mutation in Bmpr1a causes embryonic lethality before gastrulation, whereas a mutation in 
Bmp2 causes lethality after mesoderm formation [60, 61]. Alternatively, it is well accepted 
that functions of BMP signaling are context dependent, thus, it would not be surprising if 
consequences of loss of BMP signaling in osteoblasts might be different between embryonic 
and postnatal stages. In the current study, we induced Cre activity in osteoblasts at 16 weeks 
after birth while the type 1 collagen-Cre employed to disrupt Bmp2 is constitutively active 
from embryonic stages [10]. Interesting future directions would be to further investigate 
stage-dependent outcomes in bone quality and biomechanical properties by alternating levels 
of BMP signaling. Nonetheless, we think the precise regulation of BMP signaling through 
BMPR1A may have a clinical advantage to restore tissue quality and strengthen bone in 
patients with high risk of bone fracture. Suppression of BMPR1A signaling by 
administration of a soluble form of BMPR1A prevents ovariectomy-induced bone loss and 
improves bone strength [13]. Therefore, these innovative interventions would be worth 
considering in order to improve bone quality to reduce risk of fracture.
Conclusions
In this study, we have shown that loss of BMP signaling through BMPR1A in osteoblasts 
results in increased levels of mature collagen cross-links and mineral to matrix ratio in 
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trabecular compartments of femora. These compositional changes were associated with 
greater tissue-level biomechanical properties in trabecular bone, including hardness and 
elastic modulus. Loss of BMPR1A differentially affected the cortical compartment of 
femora to reduce cross-sectional area, likely leading to the decreased structure-level 
strength. These results indicate that BMP signaling mediated by BMPR1A in osteoblasts is 
an important factor for maintaining normal bone tissue quality that affect biomechanical 
properties.
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Highlights
Loss of BMPR1A in osteoblasts leads to more mature cross-links in collagen.
Loss of BMPR1A leads to a greater mineral-matrix ratio in trabecular compartments.
The hardness and elastic modulus were greater in the cKO trabecular compartments.
Loss of BMPR1A affected cortical and trabecular compartments differently.
Our results uncover novel aspects of BMP signaling on bone quality and bone mass.
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Fig. 1. Loss of BMPR1A increased non-reduced mature cross-links in collagen
HPLC measurements of collagen content by Hyl/dry ash (A), and the extent of Lys 
hydroxylation of collagen shown by the ratio of Hyl/Hyp (B), collagen immature cross-links 
(C, D, E, F), and collagen mature cross-links (G, H) in femora. HP is significantly increased 
in cKO femur (G), while there are no statistical differences in collagen content (A), the 
extent of Lys hydroxylation of collagen (B), aldehydes and reducible cross-links (C-F) and 
LP (H) between bones from control and cKO mice. (mean ± SD, t-test; *p < 0.05; n = 6 each 
group).
Hyp, Hydroxyproline; Hyl, hydroxylysine; Lys, lysyl; DHNL, droxynorleucine; HNL, 
hydroxynorleucine;, DHLNL, dihydroxylysinonorleucine; HLNL, hydroxylysinonorleucine; 
LP, Lysyl pyridinoline; HP, Hydroxylysyl pyridinoline.
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Fig. 2. Loss of BMPR1A increased the expression levels of genes related to collagen post-
translational modification
Levels of expression of genes related to collagen cross-linking were measured by QRT-PCR. 
RNAs were extracted from tibiae. Significant increases in Plod3 and Loxl4 expression were 
detected in cKO mice (mean ± SD, t-test; *p < 0.05; **p < 0.001; n = 5).
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Fig. 3. Loss of BMPR1A increased collagen mature to immature cross-link ratio and mineral to 
matrix ratio in femoral trabecular bone as measured by Raman spectroscopy
Raman spectroscopy measurements of collagen mature to immature cross-link ratios (A, B), 
mineral to matrix ratios (MMR) (C, D) and crystallinity (E, F) were evaluated in femora. 
The distal-metaphysis (End) and the mid-diaphysis (Mid) of femoral cortical compartments 
and the distal-metaphysis (End) of femoral trabecular bones were examined. Trabecular, but 
not cortical compartments of cKO femora showed significantly higher mature to immature 
cross-link ratio and mineral to matrix ratios than in controls. (mean ± SD, t-test; *p < 0.05; n 
= 6 each group).
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Fig. 4. Loss of BMPR1A increased hardness and elastic modulus in intrinsic trabecular tissues
Nanoindentation measurements of tissue-level biomechanical properties in the distal-
metaphysis (End) and mid-diaphysis (Mid) of the cortical compartment (A, C) and End 
region of the trabecular compartment (B, D) of the femur, and End region of cortical (E, G) 
and trabecular compartments (F, H) of the rib. Trabecular, but not cortical compartments of 
cKO femora showed significantly increased hardness and modulus vs. controls, and both 
compartments of cKO ribs showed significantly increased modulus vs. controls. (mean ± 
SD, t-test; *p < 0.05; n = 6 for femoral controls and cKO, n=3 for rib controls and cKO)
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Fig. 5. Loss of BMPR1A undermined the biomechanical properties at the structural-level
Structural-level properties (A, B, C, D) and estimated material-level properties (E, F, G, H) 
from the mid-diaphysis of cortical femoral compartments. (A) Force (yield, ultimate, and 
failure force), (B) deformation (yield, ultimate, failure and post-yield deformation, (C) work 
(yield and post-yield work) and (D) stiffness were evaluated in bones from control and cKO 
mice. Estimated material-level mechanical properties were calculated by normalizing 
structural-level properties by cross-sectional geometric properties and shown as (E) stress 
(yield, ultimate, and failure yield), (F) strain (yield, ultimate, failure and post-yield strain, 
(G) toughness (yield and post-yield toughness) and (H) modules. (mean ± SD, t-test; *p < 
0.05; **p < 0.001; n = 12 each group).
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TABLE 1
Standard site cross-sectional geometric properties from the mid-diaphysis of femoral 
cortical bone
Cortical area, cross-section width (M-L), and average cortical thickness were significantly
Parameters Control cKO
Cortical area (mm2) 1.26 ± 0.06 1.15 ±0.1**
Cross-sectional width: A-P (mm) 1.95 ± 0.08 1.82 ± 0.09
Cross-sectional width: M-L (mm) 1.38 ± 0.08 1.33 ±0.08**
Cross-sectional aspect ratio (A-P width/M-L
width)
1.41 ± 0.07 1.37 ± 0.06
A-P moment of inertia (mm4) 0.22 ± 0.03 0.19 ± 0.04
M-L moment of inertia (mm4) 0.40 ± 0.04 0.33 ± 0.06
Average cortical thickness (mm) 0.30 ± 0.01 0.28 ± 0.01**
Distance to tensile side (mm) 0.69 ± 0.04 0.66 ± 0.04
Bone length (mm) 17.48 ±0.46 17.47 ± 0.53
decreased in bones from cKO vs. control mice. (mean ± SD, t-test; **p < 0.01; n =12 each group).
A-P, anterior-posterior; M-L, medial-lateral.
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